Provided by Tiger Fintech (Singapore) Pte. Ltd.

Corbus Pharmaceuticals

8.08
-0.2700-3.23%
Post-market: 8.080.00000.00%19:57 EDT
Volume:226.00K
Turnover:1.87M
Market Cap:98.84M
PE:-2.19
High:8.73
Open:8.57
Low:7.92
Close:8.35
Loading ...

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
Yesterday

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
25 Apr

Corbus Pharmaceuticals Holdings Inc. Stock Rises 10.5%, Outperforms Competitors

Dow Jones
·
24 Apr

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
22 Apr

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
18 Apr

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
15 Apr

Corbus Pharmaceuticals Holdings Inc. Stock Rallies 6.2%, Outperforms Competitors

Dow Jones
·
12 Apr

Corbus Pharmaceuticals Holdings Inc. Stock Rises Wednesday, Still Underperforms Market

Dow Jones
·
10 Apr

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
08 Apr

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
03 Apr

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
02 Apr

Corbus Pharmaceuticals Holdings Inc. Stock Slips 3.8%, Underperforms Competitors

Dow Jones
·
01 Apr

Corbus Pharmaceuticals Announces First Patient Dosed in Phase 1 Clinical Study of Next-Generation CB1 Inverse Agonist Crb-913 for the Treatment of Obesity

THOMSON REUTERS
·
28 Mar

Corbus Pharmaceuticals Announces First Patient Dosed in Phase 1 Clinical Study of Next-Generation CB1 Inverse Agonist CRB-913 for the Treatment of Obesity

GlobeNewswire
·
28 Mar

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
28 Mar

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
27 Mar

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
25 Mar

Corbus Pharmaceuticals Announces Board Member Departure

TIPRANKS
·
22 Mar

Corbus Pharmaceuticals Holdings Inc. Stock Sheds 4.2%, Underperforms Competitors

Dow Jones
·
22 Mar

After Plunging -22.69% in 4 Weeks, Here's Why the Trend Might Reverse for Corbus Pharmaceuticals (CRBP)

Zacks
·
20 Mar